Periodic Reporting for period 1 - MINT (Multifunctional Immunocompatible NanoTheranostics to modulate tumor microenvironment and improve treatment monitoring: A double blow to pancreatic cancer)

Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal human malignancies having an overall 5-year survival rate less than 10%. Abundant fibrotic stroma and poor vascularization are the typical features of PDAC in humans limiting the delivery of...